EP
AGTC

Eversept Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Eversept Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,500
Closed -$106K – 71
2018
Q3 		$106K Buy
+14,500
New +$63.5K 0.05% 61

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Eversept Partners's AGTC Position: Q4 2018 in Review

Eversept Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 14,500 shares — an estimated $106K sold.

Eversept Partners first reported a position in AGTC in Q3 2018 and held it in 1 quarter. The position peaked at $106K in Q3 2018. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

  • Eversept Partners reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
  • Eversept Partners sold 14,500 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $106K.
  • Eversept Partners first reported a position in Applied Genetic Technologies Corporation in Q3 2018 and held it in 1 quarter.
  • Eversept Partners's Applied Genetic Technologies Corporation position peaked at $106K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on Eversept Partners's 13F filing for Q4 2018, filed 13 Feb 2019.